FDA Approves First-in-Class Narcolepsy Drug

The FDA has approved the first-in-class drug specifically designed to treat narcolepsy, marking a significant regulatory milestone in sleep disorder therapeutics in the United States.

This Wire brief sits within Fusion42's coverage of Drug Discovery. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.